Fig. 2: DNA vs. mRNA quantitative PCR results.

The figure displays the kinetics of the leukemic cell burden in patients treated with Imatinib mesylate after the diagnosis in early chronic phase. (I-P) The panels show the percentage of cancer cells (BCR-ABL1/BCR) as measured by gDNA qPCR (⊗DNA values, solid line) and RT–qPCR (▲RNA values, dashed line) in patients 9 to 16